Literature DB >> 26802489

Estimation of the health and economic burden of neurocysticercosis in India.

B B Singh1, M S Khatkar2, J P S Gill3, N K Dhand2.   

Abstract

Taenia solium is an endemic parasite in India which occurs in two forms in humans: cysticercosis (infection of soft tissues) and taeniosis (intestinal infection). Neurocysticercosis (NCC) is the most severe form of cysticercosis in which cysts develop in the central nervous system. This study was conducted to estimate health and economic impact due to human NCC-associated active epilepsy in India. Input data were sourced from published research literature, census data and other official records. Economic losses due to NCC-associated active epilepsy were estimated based on cost of treatment, hospitalisation and severe injury as well as loss of income. The disability-adjusted life years (DALYs) due to NCC were estimated by combining years of life lost due to early death and the number of years compromised due to disability taking the disease incidence into account. DALYs were estimated for five age groups, two genders and four regions, and then combined. To account for uncertainty, probability distributions were used for disease incidence data and other input parameters. In addition, sensitivity analyses were conducted to determine the impact of certain input parameters on health and economic estimates. It was estimated that in 2011, human NCC-associated active epilepsy caused an annual median loss of Rupees 12.03 billion (uncertainty interval [95% UI] Rs. 9.16-15.57 billion; US $ 185.14 million) with losses of Rs. 9.78 billion (95% UI Rs. 7.24-13.0 billion; US $ 150.56 million) from the North and Rs. 2.22 billion (95% UI Rs. 1.58-3.06 billion; US $ 34.14 million) from the South. The disease resulted in a total of 2.10 million (95% UI 0.99-4.10 million) DALYs per annum without age weighting and time discounting with 1.81 million (95% UI 0.84-3.57 million) DALYs from the North and 0.28 million (95% UI 0.13-0.55 million) from the South. The health burden per thousand persons per year was 1.73 DALYs (95% UI 0.82-3.39). The results indicate that human NCC causes significant health and economic impact in India. Programs for controlling the disease should be initiated to reduce the socio-economic impact of the disease in India.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Burden; Cysticercosis; Developing countries; Health and economic impact; Human NCC; India; Neglected tropical diseases; Parasitic zoonoses

Mesh:

Year:  2016        PMID: 26802489     DOI: 10.1016/j.actatropica.2016.01.017

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  21 in total

1.  Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.

Authors:  Gianfranco Arroyo; Javier A Bustos; Andres G Lescano; Isidro Gonzales; Herbert Saavedra; Silvia Rodriguez; E Javier Pretell; Pierina S Bonato; Vera L Lanchote; Osvaldo M Takayanagui; John Horton; Armando E Gonzalez; Robert H Gilman; Hector H Garcia
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

2.  A Stratified Analysis of Clinical Manifestations and Different Diagnostic Methods of Neurocysticercosis-Suspected Tamilian Population Residing in and Around Puducherry.

Authors:  Piriyatharisini Thamilselvan; Krishna Raja Muthuraman; Sheeba Arockiamary Thasan; Gayathri Kasinathan; Jharna Mandal; Subhash Chandra Parija
Journal:  J Clin Diagn Res       Date:  2017-05-01

3.  Development of a dose-response model for porcine cysticercosis.

Authors:  Daniel A Andrade-Mogrovejo; Eloy Gonzales-Gustavson; Ana C Ho-Palma; Joaquín M Prada; Gabrielle Bonnet; Francesco Pizzitutti; Luis A Gomez-Puerta; Gianfranco Arroyo; Seth E O'Neal; Hector H Garcia; Javier Guitian; Armando Gonzalez
Journal:  PLoS One       Date:  2022-03-14       Impact factor: 3.240

4.  Sub-lineages of Taenia solium Asian Genotype Recorded in North India.

Authors:  Pallavi Moudgil; Ramesh Kumar; Naresh Jindal; Aman D Moudgil
Journal:  Acta Parasitol       Date:  2022-05-26       Impact factor: 1.534

Review 5.  A scoping review of burden of disease studies estimating disability-adjusted life years due to Taenia solium.

Authors:  Andrew Larkins; Mieghan Bruce; Carlotta Di Bari; Brecht Devleesschauwer; David M Pigott; Amanda Ash
Journal:  PLoS Negl Trop Dis       Date:  2022-07-06

Review 6.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

7.  Changes in the seroprevalence of cysticercosis in suspected patients in Chandigarh, India between 1998 and 2014: analysis of 17 years of data.

Authors:  L J Robertson; H Joshi; K S Utaaker; A Kumar; S Chaudhary; K Goyal; R Sehgal
Journal:  Epidemiol Infect       Date:  2017-01-16       Impact factor: 4.434

8.  Data and the associated R code used to estimate health and economic burden of neurocysticercosis in India.

Authors:  B B Singh; M S Khatkar; J P S Gill; N K Dhand
Journal:  Data Brief       Date:  2016-03-09

9.  Assessment of the societal cost of Taenia solium in Angónia district, Mozambique.

Authors:  Chiara Trevisan; Brecht Devleesschauwer; Nicolas Praet; Alberto Pondja; Yunus Amade Assane; Pierre Dorny; Stig Milan Thamsborg; Pascal Magnussen; Maria Vang Johansen
Journal:  BMC Infect Dis       Date:  2018-03-13       Impact factor: 3.090

Review 10.  Neurocysticercosis: Current Perspectives on Diagnosis and Management.

Authors:  Caitlin Butala; T M Brook; Ayodele O Majekodunmi; Susan Christina Welburn
Journal:  Front Vet Sci       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.